Scholar Rock Holding Corp (SRRK)
NASDAQ:SRRK

Scholar Rock Holding (SRRK) Stock Price & Analysis

149 Followers

SRRK Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$4.33 - $13.00
Previous Close$6.35
Volume196.30K
Average Volume (3M)236.51K
Market Cap
$344.75M
Enterprise Value$136.96M
Total Cash (Recent Filing)$275.28M
Total Debt (Recent Filing)$67.50M
Price to Earnings (P/E)-2.2
Beta1.48
Nov 13, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.86
Shares Outstanding54,291,331
10 Day Avg. Volume218,547
30 Day Avg. Volume236,510
Standard Deviation0.27
R-Squared0.02
Alpha0.00835
Financial Highlights & Ratios
Price to Book (P/B)1.72
Price to Sales (P/S)492.50
Price to Cash Flow (P/CF)-2.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-195.66
Enterprise Value/Gross Profit4.13
Enterprise Value/Ebitda-0.81
Forecast
Price Target Upside340.94% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2


Financials

Annual

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

SRRK FAQ

What was Scholar Rock Holding Corp’s price range in the past 12 months?
Scholar Rock Holding Corp lowest stock price was $4.33 and its highest was $13.00 in the past 12 months.
    What is Scholar Rock Holding Corp’s market cap?
    Currently, no data Available
    When is Scholar Rock Holding Corp’s upcoming earnings report date?
    Scholar Rock Holding Corp’s upcoming earnings report date is Nov 13, 2023 which is in 169 days.
      How were Scholar Rock Holding Corp’s earnings last quarter?
      Scholar Rock Holding Corp released its earnings results on May 09, 2023. The company reported -$0.49 earnings per share for the quarter, beating the consensus estimate of -$0.522 by $0.032.
        Is Scholar Rock Holding Corp overvalued?
        According to Wall Street analysts Scholar Rock Holding Corp’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Scholar Rock Holding Corp pay dividends?
          Scholar Rock Holding Corp does not currently pay dividends.
          What is Scholar Rock Holding Corp’s EPS estimate?
          Scholar Rock Holding Corp’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Scholar Rock Holding Corp have?
          Scholar Rock Holding Corp has 54,291,332 shares outstanding.
            What happened to Scholar Rock Holding Corp’s price movement after its last earnings report?
            Scholar Rock Holding Corp reported an EPS of -$0.49 in its last earnings report, beating expectations of -$0.522. Following the earnings report the stock price went up 5.978%.
              Which hedge fund is a major shareholder of Scholar Rock Holding Corp?
              Among the largest hedge funds holding Scholar Rock Holding Corp’s share is Caxton Associates LP. It holds Scholar Rock Holding Corp’s shares valued at N/A.

                ---

                Scholar Rock Holding Stock Smart Score

                The Scholar Rock Holding stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Scholar Rock Holding Corp

                Scholar Rock Holding Corp. is a biopharmaceutical company, which engages in the development and discovery of innovative medicines. The company offers proprietary platform which designed to discover and develop monoclonal antibodies that have a high degree of specificity to achieve selective modulation of growth factor signaling. Its product candidate includes SRK-015 and SRK-181. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA.

                ---

                Top 5 ETFs holding SRRK

                Name
                Market Value
                Smart Score
                iShares Biotechnology ETF
                $1.76M
                8
                iShares NASDAQ US Biotechnology UCITS ETF
                $175.61K
                8
                Fidelity MSCI Health Care Index ETF
                $140.49K
                8
                Invesco Nasdaq Biotechnology ETF
                $6.34K
                8
                Dimensional U.S. Equity ETF
                $5.19K
                8
                Up to five ETFs with an Outperform Smart Score that hold SRRK. The ETFs are listed according to market value of SRRK within the ETF

                ---

                Forecast EPS vs Actual EPS


                Similar Stocks
                Company
                Price & Change
                Follow
                Biohaven Ltd.
                Atara Biotherapeutics
                Nkarta
                Monte Rosa Therapeutics
                Aura Biosciences Inc

                Popular Stocks

                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis